**AI医疗数据管理新星HiLabs获3900万美元B轮融资，加速技术创新与团队扩展**
美国华盛顿的HiLabs，一家专注于AI驱动的医疗数据解决方案的初创公司，近期在B轮融资中成功吸引了3900万美元的投资，为公司的进一步发展注入了强劲动力。本轮融资由知名投资机构Eight Roads Ventures和Denali Growth Partners共同领投，F-Prime Capital参与跟投，彰显了市场对HiLabs技术潜力和市场前景的高度认可。
HiLabs表示，这笔资金将主要用于强化其AI技术的研发，以期在医疗数据管理领域提供更高效、更精准的解决方案。同时，公司计划大力招聘全球顶尖人才，扩大产品团队，以满足日益增长的市场需求。通过这些举措，HiLabs旨在巩固其在AI医疗数据领域的领先地位，推动医疗行业的数字化转型。
HiLabs的创新技术已经在医疗行业内引起了广泛关注，其AI平台能够高效解析和分析海量医疗数据，为医生和医疗机构提供决策支持，有助于提高诊疗质量和效率。此次融资的成功，将为HiLabs的全球扩张战略提供强有力的支持，有望让更多医疗机构受益于其先进的数据管理技术。
HiLabs的B轮融资不仅是对其现有成就的肯定，也是对其未来潜力的期待。随着全球医疗领域对AI技术的日益依赖，HiLabs有望在这一变革中扮演关键角色，持续推动医疗数据管理的智能化进程。
英语如下：
**News Title:** “AI Healthcare Data Company HiLabs Secures $39 Million in Series B Funding to Accelerate Technology and Talent Expansion”
**Keywords:** HiLabs, AI Healthcare, $39 Million Financing
**News Content:**
AI healthcare data management upstart HiLabs has raised $39 million in a Series B funding round, bolstering its drive for technological innovation and team expansion. Based in Washington, USA, the startup focuses on AI-powered medical data solutions. This round was led by prominent investors Eight Roads Ventures and Denali Growth Partners, with participation from F-Prime Capital, indicating strong market confidence in HiLabs’ technological potential and market prospects.
HiLabs states that the funds will primarily be allocated to reinforce its AI technology research and development, aiming to offer more efficient and precise solutions in medical data management. Concurrently, the company intends to aggressively recruit top global talent, expanding its product team to cater to the increasing market demand. Through these efforts, HiLabs seeks to solidify its leadership position in the AI healthcare data sector and facilitate the digital transformation of the healthcare industry.
The company’s innovative technology has already garnered significant attention in the medical sector. Its AI platform efficiently parses and analyzes vast amounts of medical data, providing decision support to doctors and healthcare institutions, thus enhancing diagnostic quality and efficiency. This successful funding round will fuel HiLabs’ global expansion strategy, potentially benefiting more healthcare facilities with its advanced data management technology.
The Series B financing not only acknowledges HiLabs’ existing accomplishments but also signals anticipation for its future potential. As the global healthcare sector increasingly relies on AI technology, HiLabs is poised to play a pivotal role in this transformation, continuously propelling the智能化 of medical data management processes.
【来源】https://yourstory.com/2024/03/funding-hilabs-39-m-series-b-eight-roads-denali-growth-partners
Views: 1